These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29660376)

  • 1. New insight into isobolographic analysis for combinations of a full and partial agonist: Curved isoboles.
    Ezechiáš M; Cajthaml T
    Toxicology; 2018 Jun; 402-403():9-16. PubMed ID: 29660376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of a full and partial agonist: Experimental evidence of curved isoboles.
    Ezechiáš M
    Toxicol Lett; 2021 Oct; 350():22-29. PubMed ID: 34174339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized concentration addition: a method for examining mixtures containing partial agonists.
    Howard GJ; Webster TF
    J Theor Biol; 2009 Aug; 259(3):469-77. PubMed ID: 19345693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles.
    Grabovsky Y; Tallarida RJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):981-6. PubMed ID: 15175417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A foundation for reference models for drug combinations with an application to Loewe's reference model.
    De Mulder W; Kuiper M
    BMC Bioinformatics; 2020 Oct; 21(1):460. PubMed ID: 33059599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic activity of ternary UV filter mixtures in fish (Pimephales promelas) - an analysis with nonlinear isobolograms.
    Kunz PY; Fent K
    Toxicol Appl Pharmacol; 2009 Jan; 234(1):77-88. PubMed ID: 18992764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor partial agonism and method to express receptor partial activation with respect to novel Full Logistic Model of mixture toxicology.
    Ezechiáš M; Cajthaml T
    Toxicology; 2018 Jan; 393():26-33. PubMed ID: 29079363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between drugs and occupied receptors.
    Tallarida RJ
    Pharmacol Ther; 2007 Jan; 113(1):197-209. PubMed ID: 17079019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on "Isobolographic analysis for combinations of a full and partial agonist: curved isoboles".
    Lorenzo JI; Sánchez-Marín P
    J Pharmacol Exp Ther; 2006 Jan; 316(1):476-8; author reply 479. PubMed ID: 16371451
    [No Abstract]   [Full Text] [Related]  

  • 11. Generalized Concentration Addition Model Predicts Glucocorticoid Activity Bioassay Responses to Environmentally Detected Receptor-Ligand Mixtures.
    Medlock Kakaley E; Cardon MC; Gray LE; Hartig PC; Wilson VS
    Toxicol Sci; 2019 Mar; 168(1):252-263. PubMed ID: 30535411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].
    Pöch G
    Arzneimittelforschung; 1981; 31(7):1135-40. PubMed ID: 7196763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.
    Tallarida RJ; Raffa RB
    Pharmacol Ther; 2010 Aug; 127(2):165-74. PubMed ID: 20546783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of experimental combined toxicity by use of dose-frequency curves: comparison with theoretical additivity as well as independence.
    Pöch G; Dittrich P; Reiffenstein RJ; Lenk W; Schuster A
    Can J Physiol Pharmacol; 1990 Oct; 68(10):1338-45. PubMed ID: 2078826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists.
    Gennings C; Carter WH; Carney EW; Charles GD; Gollapudi BB; Carchman RA
    Toxicol Sci; 2004 Jul; 80(1):134-50. PubMed ID: 15084752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.
    Pöch G; Holzmann S
    J Pharmacol Methods; 1980 Sep; 4(2):179-88. PubMed ID: 7453194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative methods for assessing drug synergism.
    Tallarida RJ
    Genes Cancer; 2011 Nov; 2(11):1003-8. PubMed ID: 22737266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixtures of endocrine disruptors: how similar must mechanisms be for concentration addition to apply?
    Webster TF
    Toxicology; 2013 Nov; 313(2-3):129-33. PubMed ID: 23357612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isobolographic analysis of interactions: an update on applications and utility.
    Gessner PK
    Toxicology; 1995 Dec; 105(2-3):161-79. PubMed ID: 8571354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the isobole and related quantitative methods for assessing drug synergism.
    Tallarida RJ
    J Pharmacol Exp Ther; 2012 Jul; 342(1):2-8. PubMed ID: 22511201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.